ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
23.008,94
-1,87%
S&P 500
5.770,20
0,55%
Dow Jones
42.801,72
0,52%
Euro vs US Dollar
1,0832
-0,01%
Bitcoin
86.379,84
-0,43%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Clearmind Medicine Inc (CMND)

  7. Clearmind Medicine Inc (CMND) News

CMND

Clearmind Medicine (CMND)

Clearmind Medicine Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:CMND
DatumZeitQuelleÜberschriftSymbolFirma
19/02/202506h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:CMNDClearmind Medicine Inc
04/02/202522h01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CMNDClearmind Medicine Inc
04/02/202515h00GlobeNewswire Inc.SciSparc-Clearmind Collaboration Leads to Publication of Patent for Binge Behaviour Combination Treatment in MexicoNASDAQ:CMNDClearmind Medicine Inc
04/02/202514h35GlobeNewswire Inc.Clearmind Medicine Announces Publication of Patent for Binge Behavior Psychedelic Combination Treatment in MexicoNASDAQ:CMNDClearmind Medicine Inc
22/01/202522h30Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:CMNDClearmind Medicine Inc
22/01/202522h15Edgar (US Regulatory)Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]NASDAQ:CMNDClearmind Medicine Inc
07/01/202522h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CMNDClearmind Medicine Inc
07/01/202515h28GlobeNewswire Inc.Clearmind Medicine Announces Shareholders Meeting ResultsNASDAQ:CMNDClearmind Medicine Inc
06/01/202522h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CMNDClearmind Medicine Inc
06/01/202514h15GlobeNewswire Inc.Clearmind Medicine Announces the Publication of European Patent Application for Binge Behavior Psychedelic Combination TreatmentNASDAQ:CMNDClearmind Medicine Inc
06/01/202513h50GlobeNewswire Inc.SciSparc-Clearmind Medicine Collaboration Announces the Publication of European Patent Application for Binge Behavior Psychedelic Combination TreatmentNASDAQ:CMNDClearmind Medicine Inc
02/01/202522h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CMNDClearmind Medicine Inc
02/01/202513h45GlobeNewswire Inc.Clearmind Medicine Granted Patent for Binge Behavior Treatment by the Macau International Intellectual Property OfficeNASDAQ:CMNDClearmind Medicine Inc
26/12/202412h59GlobeNewswire Inc.Clearmind Medicine Looks to Move Forward with its Novel Psychedelic MEAI- Based Alcohol SubstituteNASDAQ:CMNDClearmind Medicine Inc
24/12/202412h55GlobeNewswire Inc.Clearmind Medicine Receives IRB Approval for its FDA-Regulated Clinical TrialNASDAQ:CMNDClearmind Medicine Inc
16/12/202414h37GlobeNewswire Inc.Clearmind Medicine and Dr Glitter Pty Ltd Sign Term Sheet for Mutual Development of Novel Psychedelic MEAI- Based Alcohol Substitute in ActivCrystal™ FormatNASDAQ:CMNDClearmind Medicine Inc
09/12/202423h12Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:CMNDClearmind Medicine Inc
06/12/202423h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CMNDClearmind Medicine Inc
20/11/202422h01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CMNDClearmind Medicine Inc
10/10/202422h01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CMNDClearmind Medicine Inc
10/10/202414h07GlobeNewswire Inc.Clearmind Medicine Announces IRB Approval for FDA First-In-Human Clinical Trial of CMND-100 at Second Clinical SiteNASDAQ:CMNDClearmind Medicine Inc
01/10/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:CMNDClearmind Medicine Inc
26/09/202422h01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CMNDClearmind Medicine Inc
24/09/202422h30Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:CMNDClearmind Medicine Inc
16/09/202422h10Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CMNDClearmind Medicine Inc
16/09/202422h06GlobeNewswire Inc.Clearmind Medicine Announces the Notice of an International Patent Application for Pioneering Ibogaine Combination TherapyNASDAQ:CMNDClearmind Medicine Inc
16/09/202422h01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CMNDClearmind Medicine Inc
12/09/202422h01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CMNDClearmind Medicine Inc
12/09/202414h20GlobeNewswire Inc.Clearmind Medicine and Yissum File International Patent Application for Revolutionary Psychedelic Compounds for PTSD TreatmentNASDAQ:CMNDClearmind Medicine Inc
06/09/202422h01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CMNDClearmind Medicine Inc
 Showing the most relevant articles for your search:NASDAQ:CMND

Kürzlich von Ihnen besucht

COIN
AVAXUSD
Avalanche
CCOM
US500
US 500
NASDAQ
AMZN
Amazon.com
NYSE
DIS
Walt Disney
NASDAQ
TSLA
Tesla
TG
MBG
MercedesBenz
CCOM
US100
US Tech 100
FX
EURUSD
Euro vs US Dollar
NASDAQ
MSFT
Microsoft
AMEX
XLV
Health Care Select Sector
TG
BAYN
Bayer
TG
LHA
Deutsche Lufthansa
NASDAQ
GOOGL
Alphabet
PM
XAUUSD
Gold vs US Dollar
AMEX
SPY
SPDR S&P 500
COIN
ADAUSD
Cardano
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten

Werbung entfernen

Melden Sie sich für ein werbefreies Erlebnis an

Keine Werbung

Versuchen Sie es jetzt

Anzeigen behalten